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Introduction
Malignant melanoma of soft parts (MMSP, also called clear cell sarcoma of soft tissue) is a rare malignant soft tissue tumor first described by Enzinger [1] and has since been accepted as a distinct clinicopathological entity. The tumor is particularly associated with tendons and aponeuroses but other tumor locations have also been reported including the head and neck, ear, penis, kidney and colon [2] . MMSP is most commonly found in young adults between the age of 20 and 40 years, but has also been described in children and elderly [3, 4] . Repeated local relapse is very common and with time, most tumors metastasize to lymph nodes, the lungs, skeleton, brain or liver [2] .
Clonal chromosome abnormalities have been described in MMSPs and the translocation t(12;22)(q13;q12) seems to be pathognomonic [5, 6] . The t(12;22) results in rearrangements of the EWSR1 gene on chromosome 22 and the ATF1 gene in 12q13 creating a chimeric EWSR1/ATF1 gene in which the 3´-terminal part of EWSR1 is replaced by the 3´-terminal part of ATF1 [7] .
Histologically, the tumor shows a characteristic architecture of nests or short fascicles of epithelioid or spindle-shaped cells with clear to granular eosinophilic cytoplasm [2] . Immunohistochemically, the tumor cells express S-100 protein, HMB-45, vimentin, and the microphthalmia transcription factor, and synthesize melanin [2] .
In a recent study, Segal et al. [8] used cDNA microarray to show that MMSP has a gene expression profile closely related to melanoma. Because MMSP shares a number of morphologic features with conventional malignant melanoma, there are diagnostic difficulties in the distinction between MMSP and metastatic malignant melanoma with an unknown primary site [2] .
Recently, a high incidence of activating mutations in the BRAF gene has been reported in melanoma cell lines, melanoma short term cultures, primary and metastatic melanomas and nevi [9] [10] [11] [12] . All the mutations were detected in the kinase domain of the BRAF gene and found in exons 11 and 15 [9] . By far, the most common mutation (V599E) is the T1796A single base substitution in exon 15, leading to an exchange of valine for glutamic acid at position 599 [9] . Mutated BRAF proteins posses ten fold higher basal kinase activity and are more than 100 times as efficient in transforming NIH3T3 as compared to the wild-type BRAF gene [9] .
Because of the extensive clinical, hictologic and genetic similarities with melanoma, we decide to analyze whether MMSP also has mutations in the BRAF gene.
Materials and methods
The material consisted of eight MMSP with an EWSR1/ATF1 chimeric transcript, the melanoma cell line SK-MEL-28 and a soft tissue metastasis from a malignant melanoma of the skin. The clinical data and the cytogenetic and molecular identification of the fusion gene have been reported [13] . For sequence analysis, the amplified fragments were run on 1.5% agarose gels, purified using the Qiagen gel extraction kit (Qiagen), and directly sequenced using the dideoxy procedure with an ABI Prism BigDye terminator cycle sequencing ready reaction kit (PE Applied Biosystems) and the same primers as for PCR on the Applied
Biosystems Model 3100-Avant DNA sequencing system.
Results and discussion
None of the MMSP was found to harbor any mutations in exon 11 or 15 of the BRAF gene whereas both malignant melanomas showed the previously described [9] exon 15 T1796A (V599E) mutation ( Figure 1) . Sequencing of the entire PCR products from the MMSP confirmed a wild-type sequence over the entire exons 11 and 15. Although the present study was limited to eight samples, it seems safe to conclude that BRAF mutations are rare in MMSP. Consequently, if BRAF is activated in MMSP (which remains to be determined) then that is unlikely to result from an intrinsic genomic mechanism. Our data further highlight the fact that MMSP is genetically different from conventional melanoma. 
